Lidocaine Versus ESP - After Bariatric Surgery

Status Recruiting

Clinical Trial Summary

The Erector Spinal Block (ESP) is based on the deposition of the local anesthetic in the inter-fascial space between the dorsal extensor muscle and the intercostal muscles at the height of the transverse processes. The scope of the blockade covers the dorsal and ventral branches of the thoracic spinal nerves, but also in most cases the investigetors are able to obtain a wide distribution of the drug into the paravertebral space by "permeating" the local anesthetic through the fascial compartments. The clinical effect of the blockade is due to blocking the nerve structures of the paravertebral space (spinal nerve branches and the sympathetic trunk). The scope of the blockade, after its execution at the level of Th5, most often includes the segments from Th1 to L1. Lidocaine used in intravenous infusion is one of the recommended components of multidirectional analgesia. Its adjuvant properties make it possible to reduce the amount of opioid drugs used, and thus - to reduce the frequency of their side effects. The aim of the study is to test the effectiveness and safety of the use of lidocaine infusion or Erector Spinal Block in multimodal analgesic management.

Clinical Trial Description

In bariatric surgery, overall pain is a conglomerate of three different and clinically separate components: incisional pain (somatic pain), visceral pain (deep intra abdominal pain), and shoulder pain due to peritoneal stretching and diaphragmatic irritation associated with carbon dioxide insufflation. Moreover, it has been hypothesized that intense acute pain after labdomen surgery may predict development of chronic pain. Without effective treatment, this ongoing pain may delay recovery, mandate inpatient admission, and thereby increase the cost of such care. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05700214
Study type	Interventional
Source	Jagiellonian University
Contact
Status	Recruiting
Phase	N/A
Start date	January 16, 2023
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02566733` - Minto Model in Effect Site Mode for Target-Controlled Infusion of Remifentanil During Cardiopulmonary Bypass	Phase 4
Completed	`NCT05601674` - The Effect of Low Flow Anesthesia on Postoperative Emergence Agitation in Rhinoplasty	N/A
Completed	`NCT04634721` - Transversus Abdominis Plan Block, Ultrasound or Laparoscopic?	N/A
Completed	`NCT01873612` - Acute Ventilatory Response to Hypoxia During Sedation With Dexmedetomidine Compared to Propofol in Healthy Male Volunteers	Phase 4
Not yet recruiting	`NCT06462196` - Natural History of Depression, Bipolar Disorder and Suicide Risk
Not yet recruiting	`NCT05406102` - Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy	Phase 4
Recruiting	`NCT04124757` - Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety	N/A
Completed	`NCT04699500` - Spanish Validation and Cross-cultural Adaptation of the QoR-15E
Completed	`NCT03817359` - Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer Surgery	N/A
Completed	`NCT01140100` - A Comparative Study of Depth of Anesthesia Monitored by Bispectral Index (BIS) Values	Phase 2